Eli Lilly and Company (lly)
LLY Dividends
| Dividend yield | 0.59% |
| Forward P/E | 25.81 |
Eli Lilly and Company FAQ
What does Eli Lilly and Company (LLY) do?
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100,…
What is LLY's P/E ratio?
Eli Lilly and Company has a trailing P/E of 39.22× based on publicly available market data.
Does LLY pay a dividend?
Indicated dividend yield: 0.6%. Confirm ex-dates and payout history in Vest Terminal.
What sector is LLY in?
Eli Lilly and Company is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is LLY's market capitalization?
Approximate market cap: $1.06T.
What are the main risks for LLY?
Key risks include elevated valuation, among factors on this page.
What are the strengths of LLY?
Potential positives include revenue growth of 47.7% year-over-year, earnings growth of 26.2% year-over-year.
Where can I get analyst estimates for LLY?
Consensus estimates, price targets, and detailed analyst data for Eli Lilly and Company are available to Professional subscribers in Vest Terminal — not on this public summary page.